Insider · CIK 0001574591

Dier Mardi

Reports to the SEC for 7 companies · WEST CONSHOHOCKEN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001574591

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−420 sh	$426.86	−$179K	13,366
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−80 sh	$435.31	−$34.8K	12,610
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−80 sh	$436.69	−$34.9K	12,530
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−116 sh	$432.56	−$50.2K	12,850
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−160 sh	$434.20	−$69.5K	12,690
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−120 sh	$430.90	−$51.7K	12,966
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−80 sh	$427.85	−$34.2K	13,286
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−40 sh	$429.58	−$17.2K	13,086
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−646 sh	$431.94	−$279K	13,826
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−40 sh	$437.65	−$17.5K	12,490
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−160 sh	$429.00	−$68.6K	13,126
2026-03-06	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−40 sh	$425.08	−$17K	13,786
2026-03-04	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CFO	AAward	+6,519 sh	—	—	6,519
2026-03-04	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	EVP and CFO	AAward	+5,215 sh	—	—	14,472
2026-03-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−1,183 sh	$427.21	−$505K	9,257
2026-01-02	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−320 sh	$577.81	−$185K	12,132
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−240 sh	$576.15	−$138K	12,452
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−120 sh	$574.95	−$69K	12,692
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−4,173 sh	—	—	9,180
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−80 sh	$596.18	−$47.7K	10,440
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−354 sh	$573.02	−$203K	13,529
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−74 sh	$595.20	−$44K	10,520
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−717 sh	$574.00	−$412K	12,812
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−160 sh	$590.37	−$94.5K	10,594
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−410 sh	$571.99	−$235K	13,883
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−160 sh	$589.65	−$94.3K	10,754
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−240 sh	$587.85	−$141K	10,914
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−320 sh	$570.39	−$183K	14,293
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−240 sh	$585.44	−$141K	11,154
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−480 sh	$579.85	−$278K	11,394
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CFO	MExercise/Conversion	+4,173 sh	$251.63	+$1.05M	14,613
2025-12-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−258 sh	$578.83	−$149K	11,874
2025-06-12	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2025-03-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−258 sh	$323.04	−$83.3K	10,440
2025-03-05	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CFO	AAward	+6,374 sh	—	—	6,374
2025-03-05	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	EVP and CFO	AAward	+3,784 sh	—	—	10,698
2025-03-03	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−774 sh	$323.54	−$250K	6,914
2025-03-03	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	EVP and CFO	SSale	−1,187 sh	$325.89	−$387K	7,688
2025-01-02	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-06-14	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2024-06-12	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25.6K sh	—	—	25,600
2023-06-16	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2023-06-14	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	CFO and CBO	JOther	−85.2K sh	—	—	0
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	CFO and CBO	JOther	+674K sh	—	—	673,621
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	CFO and CBO	JOther	−674K sh	—	—	0
2023-05-09	ACELYRIN, Inc.P Purchase	CFO and CBO	PPurchase	+875 sh	$18.00	+$15.8K	875
2023-05-09	ACELYRIN, Inc.P Purchase	CFO and CBO	PPurchase	+875 sh	$18.00	+$15.8K	875
2023-05-09	ACELYRIN, Inc.P Purchase	CFO and CBO	PPurchase	+5,556 sh	$18.00	+$100K	5,556

Recent filings

Accepted (ET)
Mar 64
Dier Mardi0001628280-26-015775
SEC(opens sec.gov)
Mar 24
Dier Mardi0001628280-26-013394
SEC(opens sec.gov)
Jan 64
Dier Mardi0001574591-26-000002
SEC(opens sec.gov)
Dec 34
Dier Mardi0001628280-25-055164
SEC(opens sec.gov)

Companies

Address

C/O MADRIGAL PHARMACEUTICALS, INC. 200 BARR HARBOR DRIVE, SUITE 200

WEST CONSHOHOCKEN, PA, 19428